Web Results

law.justia.com/cases/federal/district-courts/FSupp/922/1261/1592845

922 F. Supp. 1261 (1996). Arthur Ray BOWLING, et al., Plaintiffs, v. PFIZER, INC., et al., Defendants. No. C-1-91-256. United States District Court, S.D. Ohio, Western Division. March 1, 1996. *1262 Stanley Morris Chesley, Waite, Schneider, Bayless & Chesley Co. 1, Cincinnati, OH, for Arthur Ray Bowling, Julie Whyle, Janet ...

law.justia.com/cases/federal/appellate-courts/ca7/17-2056/17-2056-2018-01-19.html

Jan 19, 2018 ... Levine, the Supreme Court held that claims against a manufacturer of a brand- name prescription drug for failure to warn adequately of the drug's dangers were not preempted by federal law.; in PLIVA v. Mensing, the Court held that such failure-to-warn claims against manufacturers of generic drugs are ...

www.wvscblog.com/opinion-analysis/m-m-v-pfizer-inc-et-al

Nov 16, 2017 ... The petitioner, M.M., an infant, by her mother, is one of nineteen minor plaintiffs who alleged that they sustained birth defects from their mother's use of the prescription anti-depressant Zoloft. The respondent, Pfizer, manufactures and markets Zoloft. The remaining respondents, Roerig and Greenhouse, are ...

www.courts.mo.gov/file/SC96151_Schmidt_et_al_brief.pdf

Case No. SC96151. IN THE. SUPREME COURT OF MISSOURI. MIASIA BARRON, et al.,. Plaintiffs/Respondents, v. ABBOTT LABORATORIES INC.,. Defendant/Appellant. Appeal from the Circuit Court of the City of St. Louis. Hon. Steven R. Ohmer. RESPONDENTS' SUBSTITUTE BRIEF. Edward D. Robertson, Jr. #27183.

thomasdurrell.com/wp-content/uploads/2017/04/US-ex-rel-Brown-v.-pfizer.pdf

IN THE UNITED STATES DISTRICT COURT. FOR THE EASTERN DISTRICT OF PENNSYLVANIA. THE UNITED STATES OF AMERICA, et al.,. : ex rel. CATHERINE A. BROWN and. : BERNARD G. VEZEAU. : : CIVIL ACTION v. : : NO. 05-6795. PFIZER, INC. : MEMORANDUM. SURRICK, J. APRIL 11 , 2017. Presently before ...

www.supremecourt.gov/opinions/06pdf/05-608.pdf

SUPREME COURT OF THE UNITED STATES. Syllabus. MEDIMMUNE, INC. v. GENENTECH, INC., ET AL. CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR. THE FEDERAL CIRCUIT. No. 05–608. Argued October 4, 2006 —Decided January 9, 2007. After the parties entered into a patent license ...

www.supremecourt.gov/orders/courtorders/022018zor_fd9g.pdf

4 days ago ... V. LEONARD, ANDREW P. 17-334. CENTER FOR REG. REASONABLENESS V. EPA. 17-380. CONSOL ENERGY INC., ET AL. V. EEOC. 17-469. SILAIS, HERNEL V. SESSIONS, ATT'Y GEN. 17-526. ROCKINGHAM, NC, ET AL. V. FERC, ET AL. 17-531. OAK HARBOR FREIGHT LINES V. NLRB. 17-537.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3071370

Apr 5, 2011 ... Collins, et al. v. Pfizer, Inc. Civil Action 1:04-CV-11780-DPW. 2007 August 13. Available: http://www.drugepi.org/downloads/downloads/Pfizer_Complaint8.pdf. Accessed 10 February 2011. 31. US, et al. ex rel. Lauterbach v. Orphan Medical Inc., Jazz Pharmaceuticals Inc., and Dr. Peter Gleason. Civil Action ...

press.pfizer.com/press-release/new-data-continue-characterize-safety-and-efficacy-xeljanz-tofacitinib-citrate-treatme

Nov 2, 2015 ... NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today that 26 new scientific abstracts, including 20 presentations for XELJANZ® (tofacitinib .... Real World Evaluation of Patients with Rheumatoid Arthritis Initiating Tofacitinib Vs. Adalimumab and Etanercept (Chastek B, Harnett J, Curtis J, et al., ...